Publications by: Mark E. Cooper
Up a level |
Pickering, Raelene J., Tikellis, Christos, Rosado, Carlos J., Tsorotes, Despina, Dimitropoulos, Alexandra, Smith, Monique, Huet, Olivier, Seeber, Ruth M., Abhayawardana, Rekhati, Johnstone, Elizabeth K.M., Golledge, Jonathan, Wang, Yutang, Jandeleit-Dahm, Karin A., Cooper, Mark E., Pfleger, Kevin D.E., and Thomas, Merlin C. (2019) Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis. Journal of Clinical Investigation, 129 (1). pp. 406-421.
Li, Jiaze, Huynh, Pacific, Dai, Aozhi, Wu, Tieqiao, Tu, Yugang, Chow, Bryna, Kiriazis, Helen, Du, Xiao-Jun, Bach, Leon A., Wilkinson-Berka, Jennifer L., Biros, Erik, Walker, Philip, Nataatmadja, Maria, West, Malcolm, Golledge, Jonathan, Allen, Terri J., Cooper, Mark E., and Chai, Zhonglin (2018) Diabetes reduces severity of aortic aneurysms depending on the presence of cell division autoantigen 1 (CDA1). Diabetes, 67 (4). pp. 755-768.
Moran, Corey S., Biros, Erik, Krishna, Smriti M., Wang, Yutang, Tikellis, Chris, Moxon, Joseph V., Cooper, Mark E., Norman, Paul E., Burrell, Louise M., Thomas, Merlin C., and Golledge, Jonathan (2017) Resveratrol inhibits growth of experimental abdominal aortic aneurysm associated with upregulation of angiotensin-converting enzyme 2. Arteriosclerosis Thrombosis and Vascular Biology, 37 (11). pp. 2195-2218.